Skip to main content
LIFECORE BIOMEDICAL, INC. \DE\ logo

LIFECORE BIOMEDICAL, INC. \DE\ — Investor Relations & Filings

Ticker · LFCR ISIN · US5147661046 LEI · 549300EHBZ5OM9ND9O43 US Manufacturing
Filings indexed 1,096 across all filing types
Latest filing 2011-05-27 Director's Dealing
Country US United States of America
Listing US LFCR

About LIFECORE BIOMEDICAL, INC. \DE\

https://www.lifecore.com/

Lifecore Biomedical is an integrated contract development and manufacturing organization (CDMO) that specializes in sterile injectable pharmaceutical drug products and medical devices. The company provides a full range of services, including specialty formulation, process development, aseptic filling, and final packaging, supporting products from clinical phases through to commercial supply. A key area of expertise is the handling of complex and highly viscous formulations. In addition to its CDMO capabilities, Lifecore is a primary producer of non-animal-sourced sodium hyaluronate (hyaluronic acid), offering it in various molecular weights and formats, including bulk material, hydrogels, and filled syringes and vials for diverse applications.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2011-05-27 English
4 Filing
Director's Dealing
2011-05-27 English
4 Filing
Director's Dealing
2011-05-27 English
4 Filing
Director's Dealing
2011-05-27 English
8-K Filing
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically discusses the approval of performance criteria and cash bonus structures for employees and executives for the upcoming fiscal year. This relates to changes in compensatory arrangements for certain officers. There is no financial data or detailed report content, but rather an announcement of management decisions regarding compensation plans. The relevant filing category for announcements about changes in management or board-related matters, including compensatory arrangements, is 'Board/Management Information' (MANG). The document length is short and it is not a full financial report or earnings release, so it does not fit other categories like 10-K or ER. Therefore, the correct classification is MANG with high confidence.
2011-05-27 English
4 Filing
Director's Dealing
2011-05-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.